248 related articles for article (PubMed ID: 33527763)
1. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.
Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP
Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763
[TBL] [Abstract][Full Text] [Related]
2. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in human papillomavirus-associated oropharyngeal squamous cell carcinoma of patients with treatment failure.
Reder H; Wagner S; Gamerdinger U; Sandmann S; Wuerdemann N; Braeuninger A; Dugas M; Gattenloehner S; Klussmann JP; Wittekindt C
Oral Oncol; 2019 Jun; 93():59-65. PubMed ID: 31109697
[TBL] [Abstract][Full Text] [Related]
4. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
[TBL] [Abstract][Full Text] [Related]
5. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
6. The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.
Harbison RA; Kubik M; Konnick EQ; Zhang Q; Lee SG; Park H; Zhang J; Carlson CS; Chen C; Schwartz SM; Rodriguez CP; Duvvuri U; Méndez E
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046007
[TBL] [Abstract][Full Text] [Related]
7. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
8. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
10. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
[TBL] [Abstract][Full Text] [Related]
11. Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature.
Grønhøj C; Jensen DH; Agander T; Kiss K; Høgdall E; Specht L; Bagger FO; Nielsen FC; von Buchwald C
BMC Cancer; 2018 Jun; 18(1):640. PubMed ID: 29879932
[TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx.
Dogan S; Xu B; Middha S; Vanderbilt CM; Bowman AS; Migliacci J; Morris LGT; Seshan VE; Ganly I
Int J Cancer; 2019 Dec; 145(11):3152-3162. PubMed ID: 31093971
[TBL] [Abstract][Full Text] [Related]
13. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.
Jouhi L; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Hagström J
Cancer Immunol Immunother; 2017 Dec; 66(12):1619-1629. PubMed ID: 28856441
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
Chakravarthy A; Henderson S; Thirdborough SM; Ottensmeier CH; Su X; Lechner M; Feber A; Thomas GJ; Fenton TR
J Clin Oncol; 2016 Dec; 34(34):4132-4141. PubMed ID: 27863190
[TBL] [Abstract][Full Text] [Related]
16. Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas.
Gao G; Wang J; Kasperbauer JL; Tombers NM; Teng F; Gou H; Zhao Y; Bao Z; Smith DI
BMC Cancer; 2019 Apr; 19(1):352. PubMed ID: 30975103
[TBL] [Abstract][Full Text] [Related]
17. Copy number gain of 11q13.3 genes associates with pathological stage in hypopharyngeal squamous cell carcinoma.
Pattle SB; Utjesanovic N; Togo A; Wells L; Conn B; Monaghan H; Junor E; Johannessen I; Cuschieri K; Talbot S
Genes Chromosomes Cancer; 2017 Mar; 56(3):185-198. PubMed ID: 27750372
[TBL] [Abstract][Full Text] [Related]
18. DNA-Pk
Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
[TBL] [Abstract][Full Text] [Related]
19. Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.
Sewell A; Brown B; Biktasova A; Mills GB; Lu Y; Tyson DR; Issaeva N; Yarbrough WG
Clin Cancer Res; 2014 May; 20(9):2300-11. PubMed ID: 24599934
[TBL] [Abstract][Full Text] [Related]
20. Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts.
Lilja-Fischer JK; Ulhøi BP; Alsner J; Stougaard M; Thomsen MS; Busk M; Lassen P; Steiniche T; Nielsen VE; Overgaard J
Acta Oncol; 2019 Oct; 58(10):1489-1494. PubMed ID: 31510843
[No Abstract] [Full Text] [Related]
[Next] [New Search]